HCPCS Level II · Outpatient PPS (temporary codes)
C9058Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg
Terminated 06/30/2020
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About C9058
C9058 is an HCPCS Level II code in the C series (outpatient PPS (temporary codes)), describing injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg.
It was added to HCPCS effective 11/15/2019, and its current record took effect 07/01/2020.
It was terminated on 06/30/2020 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Injection,pegfilgrastim-bmez
- Date added
- 11/15/2019
- Action effective
- 07/01/2020
- Termination date
- 06/30/2020
- BETOS
- O1E
Related C90xx codes
Common questions about C9058
Is HCPCS C9058 still valid?
- No. C9058 was terminated on 06/30/2020.
Does Medicare cover C9058?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.